Literature DB >> 9513627

Community reinforcement approach in the treatment of opiate addicts.

P J Abbott1, S B Weller, H D Delaney, B A Moore.   

Abstract

The authors studied the efficacy of the community reinforcement approach (CRA) as compared to standard counseling in opiate-dependent patients on methadone maintenance. One hundred eighty subjects were randomized to three treatment conditions: standard, CRA, and CRA with relapse prevention (CRA/RP). Of these, 151 subjects were followed up 6 months after intake. Since few of the RP sessions had been concluded at the 6-month follow-up, the two CRA groups were combined for analyses. Weekly urinalysis drug screens and Addiction Severity Index (ASI) scores at intake and 6 months were compared. The combined CRA groups did significantly better than the standard group in the following areas: consecutive opiate-negative urinalysis (3 weeks), and the 6-month ASI drug composite score. These results support the benefit of adding CRA strategies to the treatment of patients who are opiate dependent and on methadone maintenance. Because of insufficient treatment exposure to RP at the 6-month follow-up, the additive effect of RP could not be adequately evaluated; further follow-up will be required.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9513627     DOI: 10.3109/00952999809001696

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  12 in total

Review 1.  Advances in the psychosocial treatment of addiction: the role of technology in the delivery of evidence-based psychosocial treatment.

Authors:  Lisa A Marsch; Jesse Dallery
Journal:  Psychiatr Clin North Am       Date:  2012-04-11

Review 2.  The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence.

Authors:  Steven Simoens; Catriona Matheson; Christine Bond; Karen Inkster; Anne Ludbrook
Journal:  Br J Gen Pract       Date:  2005-02       Impact factor: 5.386

Review 3.  Cognitive behavioral therapy for substance use disorders.

Authors:  R Kathryn McHugh; Bridget A Hearon; Michael W Otto
Journal:  Psychiatr Clin North Am       Date:  2010-09

Review 4.  Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection.

Authors:  Linda R Gowing; Michael Farrell; Reinhard Bornemann; Lynn E Sullivan; Robert L Ali
Journal:  J Gen Intern Med       Date:  2005-12-07       Impact factor: 5.128

Review 5.  Current developments in psychosocial treatments of alcohol and substance abuse.

Authors:  L Siqueland; P Crits-Christoph
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

6.  Latent Profiles of Health and Reproductive Risk and Protective Factors among Women in Appalachia.

Authors:  Braden K Linn; Gretchen E Ely; Michele Staton
Journal:  J Soc Work Pract Addict       Date:  2020-04-07

7.  Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial.

Authors:  Warren K Bickel; Lisa A Marsch; August R Buchhalter; Gary J Badger
Journal:  Exp Clin Psychopharmacol       Date:  2008-04       Impact factor: 3.157

8.  Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment.

Authors:  Lisa A Marsch; Honoria Guarino; Michelle Acosta; Yesenia Aponte-Melendez; Charles Cleland; Michael Grabinski; Ronald Brady; Joyce Edwards
Journal:  J Subst Abuse Treat       Date:  2013-09-21

9.  Improving psychosocial health and employment outcomes for individuals receiving methadone treatment: a realist synthesis of what makes interventions work.

Authors:  Lois A Jackson; Jane A Buxton; Julie Dingwell; Margaret Dykeman; Jacqueline Gahagan; Karen Gallant; Jeff Karabanow; Susan Kirkland; Dolores LeVangie; Ingrid Sketris; Michael Gossop; Carolyn Davison
Journal:  BMC Psychol       Date:  2014-09-07

Review 10.  The community reinforcement approach: an update of the evidence.

Authors:  Robert J Meyers; Hendrik G Roozen; Jane Ellen Smith
Journal:  Alcohol Res Health       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.